Progression of prostate cancer and multi-drug-resistant tumour was significantly associated with PI3kinase pathway hyperactivation, either due to PTEN modulation or due to hyperactivation of PIK3CA, AKT, mTOR or any other proteins of the pathway 21. The gene discussed is AKT1; the disease is neoplasm.